Healthcare
Live Price
Offline$7.30
+0.00% today
1Y Change
-68.53%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Takara Bio Inc. (TKBIF) is a Healthcare stock with a market cap of $137.39B and listed on OTC. The stock last traded around $7.30 and down 68.5% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin -2.5% and ROIC -0.9%. Valuation is more restrained than many high-expectation growth names at price/sales 3.1. Stock Foundry combines TKBIF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TKBIF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TKBIF Max Drawdown
-78.45%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TKBIF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
Latest Revenue
—
Latest Net Income
—
Free Cash Flow
—
Revenue Growth
+0.0%
EPS Growth
+0.0%
Gross Margin
54.0%
Net Margin
-16.3%
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.